Table 1.
SOT recipients should avoid close contact with individuals with respiratory tract infections. AII |
All SOT recipients and candidates should receive annual seasonal influenza vaccination. AII |
Household members and HCWs in contact with SOT recipients should also receive influenza vaccination. AII |
Live‐attenuated influenza vaccine is not recommended in SOT recipients. DII |
In selected patients to whom influenza vaccine cannot be administered, prophylaxis with oseltamivir 75 mg/day for 12 weeks during the influenza season may be proposed. CI |
The use of palivizumab for prevention of respiratory syncytial virus infection is not recommended in SOT recipients. CIII |
SOT, solid organ transplant; HCW, healthcare workers.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.